BioCorRx Inc. (BICX) intrinsic value & 10-year financials
BioCorRx Inc. (BICX) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 1.4% a year to $797.2K, with an average return on invested capital of 136.6%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.25
- Market cap
- $4.6M
- Revenue (FY2025)
- $797.2K
- Revenue growth (10-yr CAGR)
- 1.4%
- ROIC (10-yr avg)
- 136.6%
- Free cash flow (FY2025)
- —
BICX 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $797.2K | -$3.4M | -$0.19 | — | -606.0% | 41.5% |
| FY2024 | $7.7K | -$5.2M | -$0.49 | — | -66829.8% | 46.7% |
| FY2023 | $89.2K | -$3.8M | — | — | -4248.3% | 42.2% |
| FY2022 | $213.8K | -$4.4M | — | -$2.0M | -2197.0% | 64.5% |
| FY2021 | $48.3K | -$5.2M | — | -$3.6M | -11414.7% | 101.6% |
| FY2020 | $122.6K | -$3.5M | — | -$2.2M | -6109.9% | 196.0% |
| FY2019 | $240.3K | -$6.0M | — | -$3.1M | -2314.7% | 169.7% |
| FY2018 | $376.7K | -$6.6M | — | -$1.8M | -1228.2% | 137.2% |
| FY2017 | $657.3K | -$29.7M | — | -$2.5M | -439.8% | 494.1% |
| FY2016 | $701.8K | -$5.9M | — | -$2.3M | -310.9% | 72.6% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
BioCorRx Inc. has demonstrated mature, steady growth, with revenue compounding at 1.4% annually over the past decade.
BioCorRx Inc. has earned high returns on invested capital, averaging 51.5% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Over the decade, BioCorRx Inc. shows that management has aggressively returned capital to shareholders by retiring 92.6% of outstanding shares.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, BioCorRx Inc. is modeled at 1.4% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-1.86 per share.